Stock comparison
AnaptysBio
ANAB$1.68BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$104.11BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
ANAB 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
ANAB0wins
7winsSANOFICONR.NS
27F
B78
64C
A89
41F
B83
75B
B77
52D
A91
33F
A86
28F
A85
Side-by-side metrics
| Metric | ANAB | SANOFICONR.NS |
|---|---|---|
| Market cap | $1.68B | $104.11B Winner |
| P/E (TTM) | Winner: - | 44.2x |
| EV/EBIT | 55.0x | 31.8x Winner |
| ROIC (TTM) | 14.06% | 59.15% Winner |
| Gross margin | Winner: 116.42% | 68.13% |
| Net margin | -11.53% | 27.35% Winner |
| Revenue CAGR 5y | Winner: 38.82% | 27.01% |
| EPS CAGR 5y | - | 20.67% |
| Debt / Equity | 21.8x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ANAB leads on
- P/E (TTM)-vs 44.2x+168%
- Gross margin116.42%vs 68.13%+41%
- Revenue CAGR 5y38.82%vs 27.01%+30%
SANOFICONR.NS leads on
- Net margin27.35%vs -11.53%+142%
- Debt / Equity0.1xvs 21.8x+100%
- Market cap$104.11Bvs $1.68B+98%
- ROIC (TTM)59.15%vs 14.06%+76%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.